Medical Program: Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer

Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer

Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
RestartResume

The non-small cell lung cancer therapeutic landscape is rapidly evolving as these local, systemic, and combination treatments are being introduced. 

  • Overview

    To help us treat the disease representing the most common cause of cancer mortality worldwide—with more than half of patients presenting with stage IV disease at diagnosis—Dr. Jennifer Caudle speaks with Dr. Stephen Liu, who reviews the various recommended first-line systemic therapies for non-small cell lung cancer, the rationales behind single agents versus combinations, and strategies to guide patients through their treatment course. 

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free